In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Contineum Therapeutics Inc (NASDAQ: CTNM) closed at $4.11 up 2.49% from its previous closing price of $4.01. In other words, the price has increased by $2.49 from its previous closing price. On the day, 1.3 million shares were traded. CTNM stock price reached its highest trading level at $4.35 during the session, while it also had its lowest trading level at $3.97.
Ratios:
For a deeper understanding of Contineum Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 21.47 and its Current Ratio is at 21.47. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
On October 22, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $32.
On April 30, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $29.Stifel initiated its Buy rating on April 30, 2024, with a $29 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 25 ’24 when Lorrain Daniel S. sold 1,010 shares for $16.02 per share. The transaction valued at 16,177 led to the insider holds 168,562 shares of the business.
Lorrain Daniel S. sold 6,190 shares of CTNM for $101,421 on Nov 18 ’24. The Chief Scientific Officer now owns 169,572 shares after completing the transaction at $16.38 per share. On Nov 18 ’24, another insider, DANIEL LORRAIN, who serves as the Officer of the company, bought 26,370 shares for $17.21 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CTNM now has a Market Capitalization of 106332280 and an Enterprise Value of -78375936.
Stock Price History:
The Beta on a monthly basis for CTNM is 0.78, which has changed by -0.8042857 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, CTNM has reached a high of $22.00, while it has fallen to a 52-week low of $3.35. The 50-Day Moving Average of the stock is -1.80%, while the 200-Day Moving Average is calculated to be -60.97%.
Shares Statistics:
For the past three months, CTNM has traded an average of 110.15K shares per day and 287200 over the past ten days. A total of 19.14M shares are outstanding, with a floating share count of 13.50M. Insiders hold about 47.82% of the company’s shares, while institutions hold 43.22% stake in the company. Shares short for CTNM as of 1749772800 were 774117 with a Short Ratio of 7.03, compared to 1747267200 on 606931. Therefore, it implies a Short% of Shares Outstanding of 774117 and a Short% of Float of 4.5600000000000005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
